Stock CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Real-time Estimate Cboe BZX
Other stock markets
 11:15:46 2024-04-25 am EDT 		5-day change 1st Jan Change
227 USD -5.17% Intraday chart for Charles River Laboratories International, Inc. -0.52% -4.24%
02:00pm FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids CI
Apr. 24 Charles River Laboratories Files Supplement to Definitive Proxy Statement with the Securities and Exchange Commission CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids
CI
Charles River Laboratories International : Proxy Supplement Filed April 24, 2024
PU
Charles River Laboratories Files Supplement to Definitive Proxy Statement with the Securities and Exchange Commission
CI
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
BU
Charles River Laboratories International : 2023 Corporate Citizenship Report
PU
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
BU
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
CI
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
AQ
Zacks Investment Research Adjusts Charles River Laboratories International's Price Target to $259 From $278
MT
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
BU
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
BU
Charles River Laboratories International, Inc. and Deciphex Limited Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
CI
Charles River Laboratories, Axovia Therapeutics Collaborate on Developing Rare Disease Gene Therapies
MT
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
BU
Charles River Laboratories International, Inc. Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
CI
Charles River Laboratories Signs Plasmid DNA Manufacturing Deal With Ship of Theseus
MT
Charles River to Perform Plasmid Production for Ship of Theseus
BU
Charles River to Perform Plasmid Production for Ship of Theseus
BU
Charles River Laboratories International, Inc. and Ship of Theseus Announces Good Manufacturing Practice Plasmid DNA Contract Development and Manufacturing Organization Agreement
CI
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRL Stock
  4. News Charles River Laboratories International, Inc.